114 related articles for article (PubMed ID: 24685680)
21. p62/sequestosome 1 regulates aggresome formation of pathogenic ataxin-3 with expanded polyglutamine.
Zhou L; Wang H; Chen D; Gao F; Ying Z; Wang G
Int J Mol Sci; 2014 Aug; 15(9):14997-5010. PubMed ID: 25158237
[TBL] [Abstract][Full Text] [Related]
22. The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils.
Masino L; Nicastro G; De Simone A; Calder L; Molloy J; Pastore A
Biophys J; 2011 Apr; 100(8):2033-42. PubMed ID: 21504740
[TBL] [Abstract][Full Text] [Related]
23. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.
Burnett B; Li F; Pittman RN
Hum Mol Genet; 2003 Dec; 12(23):3195-205. PubMed ID: 14559776
[TBL] [Abstract][Full Text] [Related]
24. Structural transformation of the tandem ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains.
Song AX; Zhou CJ; Peng Y; Gao XC; Zhou ZR; Fu QS; Hong J; Lin DH; Hu HY
PLoS One; 2010 Oct; 5(10):e13202. PubMed ID: 20949063
[TBL] [Abstract][Full Text] [Related]
25. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites.
Nicastro G; Masino L; Esposito V; Menon RP; De Simone A; Fraternali F; Pastore A
Biopolymers; 2009 Dec; 91(12):1203-14. PubMed ID: 19382171
[TBL] [Abstract][Full Text] [Related]
26. PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner.
Jia NL; Fei EK; Ying Z; Wang HF; Wang GH
Neurosci Bull; 2008 Aug; 24(4):201-8. PubMed ID: 18668148
[TBL] [Abstract][Full Text] [Related]
27. Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.
Bonanomi M; Natalello A; Visentin C; Pastori V; Penco A; Cornelli G; Colombo G; Malabarba MG; Doglia SM; Relini A; Regonesi ME; Tortora P
Hum Mol Genet; 2014 Dec; 23(24):6542-52. PubMed ID: 25030034
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin.
Zhao Z; Xu H; Gong W
Protein Pept Lett; 2010 May; 17(5):555-8. PubMed ID: 19961433
[TBL] [Abstract][Full Text] [Related]
29. Ataxin-3 protects cells against H2O2-induced oxidative stress by enhancing the interaction between Bcl-X(L) and Bax.
Zhou L; Wang H; Wang P; Ren H; Chen D; Ying Z; Wang G
Neuroscience; 2013 Jul; 243():14-21. PubMed ID: 23562578
[TBL] [Abstract][Full Text] [Related]
30. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
31. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1.
Mizutani A; Wang L; Rajan H; Vig PJ; Alaynick WA; Thaler JP; Tsai CC
EMBO J; 2005 Sep; 24(18):3339-51. PubMed ID: 16121196
[TBL] [Abstract][Full Text] [Related]
32. The relationship between aggregation and toxicity of polyglutamine-containing ataxin-3 in the intracellular environment of Escherichia coli.
Invernizzi G; Aprile FA; Natalello A; Ghisleni A; Penco A; Relini A; Doglia SM; Tortora P; Regonesi ME
PLoS One; 2012; 7(12):e51890. PubMed ID: 23251648
[TBL] [Abstract][Full Text] [Related]
33. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step.
Ellisdon AM; Thomas B; Bottomley SP
J Biol Chem; 2006 Jun; 281(25):16888-16896. PubMed ID: 16624810
[TBL] [Abstract][Full Text] [Related]
34. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Matos CA; de Macedo-Ribeiro S; Carvalho AL
Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
[TBL] [Abstract][Full Text] [Related]
35. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways.
Chai Y; Berke SS; Cohen RE; Paulson HL
J Biol Chem; 2004 Jan; 279(5):3605-11. PubMed ID: 14602712
[TBL] [Abstract][Full Text] [Related]
36. Temperature profoundly affects ataxin-3 fibrillogenesis.
Apicella A; Natalello A; Frana AM; Baserga A; Casari CS; Bottani CE; Doglia SM; Tortora P; Regonesi ME
Biochimie; 2012 Apr; 94(4):1026-31. PubMed ID: 22234302
[TBL] [Abstract][Full Text] [Related]
37. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
38. Structural and functional analysis of ataxin-2 and ataxin-3.
Albrecht M; Golatta M; Wüllner U; Lengauer T
Eur J Biochem; 2004 Aug; 271(15):3155-70. PubMed ID: 15265035
[TBL] [Abstract][Full Text] [Related]
39. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.
Chou AH; Chen YL; Hu SH; Chang YM; Wang HL
Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423
[TBL] [Abstract][Full Text] [Related]
40. Ataxin-3 is a multivalent ligand for the parkin Ubl domain.
Bai JJ; Safadi SS; Mercier P; Barber KR; Shaw GS
Biochemistry; 2013 Oct; 52(42):7369-76. PubMed ID: 24063750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
